STAT1 transcriptionally regulates the expression of S1PR1 by binding its promoter region-Reference-Cited by-同舟云学术

STAT1 transcriptionally regulates the expression of S1PR1 by binding its promoter region

Published:2020-04 Issue: Volume:736 Page:144417
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Xin Qian,Cheng Guanghui,Kong Feng,Ji Qinghong,Li Haizhen,Jiang Wen,Wang Jue,Luan Yun,Sun Chao,Chen Xiaojing,Wang Xuexiang,Qi Tonggang,Xu Dawei,Song Lei,Liu Qiji^ORCID

Funder

National Natural Science Foundation

Natural Science Foundation of Shandong Province

Shandong University

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference40 articles.

1. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells;Bach;Mol. Cell Biol.,1996

2. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4;Bankovich;J. Biol. Chem.,2010

3. Common marker genes identified from various sample types for systemic lupus erythematosus;Bing;PLoS One,2016

4. Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients;Canto;J. Neuroinflammation,2018

5. Kruppel-like factor 2 regulates thymocyte and T-cell migration;Carlson;Nature,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells;2024-08-06

2. The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB;PLOS ONE;2024-06-26

3. Computational analysis of circadian-rhythm dysregulated genes exhibiting undifferential expression in Oryza sativa;New Zealand Journal of Crop and Horticultural Science;2024-05-08

4. Interferon-γ production by Tfh cells is required for CXCR3+ pre-memory B cell differentiation and subsequent lung-resident memory B cell responses;Immunity;2023-10

5. Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases;International Immunopharmacology;2023-09